Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole McFarlane

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating CellsChitra Venugopal, Robin Hallett, Parvez Vora, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Oncotarget|August 29, 2015
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activationMohini Singh, Neha Garg, Chitra Venugopal, et al.
Cell Stem Cell|May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for GlioblastomaParvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating CellsChitra Venugopal, Robin Hallett, Parvez Vora, et al.
Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.
Oncotarget|August 29, 2015
STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activationMohini Singh, Neha Garg, Chitra Venugopal, et al.
Cell Stem Cell|May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for GlioblastomaParvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Oncogene|October 24, 2018
BMI1 is a therapeutic target in recurrent medulloblastomaDavid Bakhshinyan, Chitra Venugopal, Ashley A Adile, et al.
Pageof 4